BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 2042339)

  • 1. [The use of ceruloplasmin in combination with adjuvant polychemotherapy in stomach cancer].
    Shchepotin IB; Chernyĭ VA; Berdinskikh NK; Sanina OL; Baraboĭ VA; Starosel'skiĭ IV; Korobko VB; Kamenets LIa; Iaremenko LIa
    Vrach Delo; 1991 Mar; (3):24-7. PubMed ID: 2042339
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The intraperitoneal administration of chemical preparations and taktivin in the combined treatment of stomach cancer].
    Shchepotin IB; Chernyĭ VA; Grinevich IuA; Kamenets LIa; Osinskiĭ SP
    Vrach Delo; 1988 Sep; (9):3-6. PubMed ID: 3212989
    [No Abstract]   [Full Text] [Related]  

  • 3. [Immunomodulating effects of indomethacin in breast cancer].
    Polevaia EB; Chikvashvili BSh; Kupin VI; Letiagin VP
    Sov Med; 1987; (8):27-30. PubMed ID: 3423958
    [No Abstract]   [Full Text] [Related]  

  • 4. [Optimization of chemotherapy of stomach cancer].
    Chernyĭ VA; Shchepotin IB
    Vrach Delo; 1989 Jun; (6):10-2. PubMed ID: 2781744
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phase II trial of combined 5-fluorouracil plus doxorubicin plus cisplatin (FAP regimen) in advanced gastric carcinoma.
    Rougier P; Droz JP; Theodore C; Piot G; Herait P; Ruffie P; Carde P; Cvitkovic E
    Cancer Treat Rep; 1987 Dec; 71(12):1301-2. PubMed ID: 3690544
    [No Abstract]   [Full Text] [Related]  

  • 6. Adjuvant postoperative therapy of gastrointestinal malignancies.
    Ilson DH; Kelsen DP
    Oncology (Williston Park); 1994 Jul; 8(7):75-83; discussion 83, 88-90, 95. PubMed ID: 7917843
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phase I--II study of the combination of 5-FU, doxorubicin, mitomycin, and semustine (FAMMe) in the treatment of adenocarcinoma of the stomach, gastroesophageal junction, and pancreas.
    Karlin DA; Stroehlein JR; Bennetts RW; Jones RD; Heifetz LJ; Mahal PS
    Cancer Treat Rep; 1982 Aug; 66(8):1613-7. PubMed ID: 7105051
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Individualization of polychemotherapy for stage III breast cancer based on immunologic status].
    Sabala PI
    Vopr Onkol; 1984; 30(11):44-8. PubMed ID: 6516259
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Natural killer and lymphokine-activated killer activities in stomach cancer patients with special emphasis on the effect of 5-fluorouracil, adriamycin and mitomycin-C chemotherapy.
    Hong WS; Kim CM; Lee JO; Kang TW; Yun TK; Kim CY
    Jpn J Clin Oncol; 1990 Mar; 20(1):87-93. PubMed ID: 2108272
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Regarding the article "Adjuvant chemotherapy in gastric cancer. Experience at the National Institute of Nutrition"].
    Sulkes A
    Rev Invest Clin; 1993; 45(1):94. PubMed ID: 8484072
    [No Abstract]   [Full Text] [Related]  

  • 11. Expression of thymidylate synthase in gastric cancer patients treated with 5-fluorouracil and doxorubicin-based adjuvant chemotherapy after curative resection.
    Choi J; Lim H; Nam DK; Kim HS; Cho DY; Yi JW; Kim HC; Cho YK; Kim MW; Joo HJ; Lee KB; Kim KB
    Br J Cancer; 2001 Jan; 84(2):186-92. PubMed ID: 11161374
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemotherapy of gastric cancer: a review.
    Kelsen D
    Isr J Med Sci; 1988; 24(9-10):557-61. PubMed ID: 3060446
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Meta-analysis of 10 postoperative adjuvant chemotherapies for gastric cancer in CIH].
    Nakajima T; Ota K; Ishihara S; Oyama S; Nishi M; Hamashima N
    Gan To Kagaku Ryoho; 1994 Aug; 21(11):1800-5. PubMed ID: 8080299
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adjuvant and neoadjuvant therapy for gastric cancer.
    Kelsen DP
    Semin Oncol; 1996 Jun; 23(3):379-89. PubMed ID: 8658222
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Present status of surgical adjuvant chemotherapy of gastric cancer].
    Taguchi T
    Gan To Kagaku Ryoho; 1989 Jun; 16(6):2169-72. PubMed ID: 2500066
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Conditions suitable for the adjuvant chemotherapy of gastric cancer].
    Nakajima T; Takahashi T; Takagi K; Kuno K; Kajitani T
    Gan No Rinsho; 1983 Aug; 29(10):1229-36. PubMed ID: 6415314
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The antioxidant ceruloplasmin: its effect on lipid peroxidation, blood rheology and the course of stenocardia].
    Zakirova AN; Mingazetdinova LN; Kamilov FKh; Lankin VZ; Lebedev AV; Konovalova GG
    Ter Arkh; 1994; 66(9):24-8. PubMed ID: 7992206
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute non-lymphocytic leukemia following FAM combination adjuvant chemotherapy for gastric and lung adenocarcinoma.
    Bouillet T; Lepage E; Gisselbrecht C; Boiron M
    Nouv Rev Fr Hematol (1978); 1990; 32(3):207-9. PubMed ID: 2120675
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Adjuvant chemotherapy in patients with radical resection of stomach cancer: 5-year results of a prospective randomized study].
    Jakesz R; Dittrich C; Funovics J; Hofbauer F; Rainer H; Reiner G; Schemper M; Schiessel R; Starlinger M
    Wien Klin Wochenschr; 1986 Dec; 98(24):824-30. PubMed ID: 3103336
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemotherapy of gastric cancer.
    Schein PS
    Acta Chir Scand Suppl; 1988; 541():13-5. PubMed ID: 2455406
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.